Luciana Molinero to Receptors, Estrogen
This is a "connection" page, showing publications Luciana Molinero has written about Receptors, Estrogen.
Connection Strength
0.038
-
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):44-59.
Score: 0.038